The Lupus Foundation of America is proud to present a series of audio podcasts on various aspects of lupus during Lupus Awareness Month. A new podcast will be posted each week and will feature experts in the field of lupus research and treatment. For more information, please visit www.lupus.org/awareness Topics: understanding lupus, lupus foundation of america
Living with Lupus Teleconference presented by Don Thomas, M.D., FACP, FACR, CCD An introduction to effective management and basics of lupus for the newly diagnosed or anyone who needs it. Current, medically accurate info on lupus, its symptoms, treatments, & coping techniques. Topics: Lupus, Lupus Foundation of America, Living with Lupus, Lupus disease
Audio podcast on kidneys and lupus from the Lupus Foundation of America, recorded Thursday, February 24, 2011 1pm-2pm EST. Presenter: Ellen Ginzler, MD, MPH Topics: kidneys, lupus, lupus nephritis, lupus foundation of america
Audio podcast on Living with Lupus from the Lupus Foundation of America, recorded Saturday, September 29, 2010. Presenter: Dr. Bonnie Bermas, Brigham and Women's Hospital. Topics: living with lupus, lupus, lupus foundation of america
Audio podcast on Newly Diagnosed with lupus from the Lupus Foundation of America, recorded July 29, 2010. Presenter: Dr. Diane Kamen, Medical University of South Carolina. Topics: newly diagnosed, lupus, diagnosis, lupus foundation of america, MUSC
Audio podcast on being newly diagnosed with lupus from the Lupus Foundation of America, February 22, 2010. Presenter: Dr. Kenneth Kalunian, University of California, San Diego. Topics: newly diagnosed, lupus, diagnosis, lupus foundation of america
Audio podcast on living with lupus from the Lupus Foundation of America, recorded May 27, 2010. Presenter: Dr. David Wofsy, University of California, San Francisco. Topics: living with lupus, lupus, lupus foundation of america
Vikki Abrahams, PhD, Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine, discusses data from her study that was supported by the Lupus Foundation of America national lupus research program. The study looked at the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome. Topics: lupus, SLE, antiphospholipid antibodies, APS, lupus foundation of america, lupus research
Treat-to-target is a treatment approach where the physician and the patient agree on specific goals, methods and deadlines for achieving specific outcomes. If the agreed upon treatment strategy does not move toward the goal, the strategy is changed. Treatment goals focus on achieving measurable improvements to the patient’s quality of life.This concept has been used successfully in other diseases, including rheumatoid arthritis and diabetes. Given its success in improving patients’... Topics: lupus, SLE, treat-to-target, medical research, lupus foundation of america
The Lupus Foundation of America's Michael Jon Barlin Pediatric Lupus Research Program provides funding to facilitate research related to childhood lupus. Dr. Hermine Brunner, Professor of Pediatrics at the Cincinnati Children's Hospital, has received funding from the Lupus Foundation of America to conduct research on health-related quality of life in children and adolescents with lupus. In this podcast, she discusses her research in this important area. Topics: pediatric lupus, cSLE, HRQOL, health related quality of life, lupus research, lupus foundation of...
Dr. Murray Urowitz, of the University of Toronto University Health Network, provides an overview of a new analysis of data from a phase II clinical study of cCDR1 (Edratide) as a potential new therapy for systemic lupus. The analysis was published online in the Lupus Foundation of America's online Open Access journal, Lupus Science & Medicine. Read the full article online for free. For more information about lupus, visit the Lupus Foundation of America's website at lupus.org. Topics: cCDR1, Edratide, SLE, lupus, clinical research, phase II, lupus foundation of america, lupus...
byLupus Foundation of America, Inc. National Office
Theresa Lawrence Ford, M.D., Medical Director, North Georgia Rheumatology Group Lawrenceville, Georgia discusses the EMBODY Program, a Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study of the efficacy and safety of the investigational drug epratuzumab for the potential treatment of Systemic Lupus Erythematosus in people with moderate to severe disease. Topics: lupus, systemic lupus erythematosus, SLE, embody, epratuzumab, clinical study, lupus treatment,...